ICAM1 and marginal zone lymphoma: There was a total of 18 cases aberrantly expressing CD54, which included 10% (1/10) of CLL/SLL cases, 69.23% (9/13) of MCL, 14.29% (2/14) of FL, 55.56% (5/9) of MZL, and 33.33% (1/3) of HG B-NHL.